Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > Tweets keep on a rollin'

<< Previous

Bullboard Posts

Next >>

Post by Pareto8020on Mar 16, 2021 6:35am

368 Views

Post# 32805671

Tweets keep on a rollin'

They aren't easy up on the TFC-167 tweets that is for sure. Now we just need more news on the higher concentration trial and find out who is their big pharma partner assisting with the trial. Be nice if this partner said you know what - we like what we see and want to get exclusive rights to it....... here is a crazy big cheque.

https://twitter.com/SironaBiochem/status/1371770009115058177?s=20

https://twitter.com/SironaBiochem/status/1371763710021279744?s=20

<< Previous

Bullboard Posts

Next >>

Revolutionizing medical imaging with nanocarbon-based contrast drugs